X

Constronics Infra Ltd Stock Analysis

Small Cap
Evaluated by 40 users | BSE: 523844 | NSE: |
Hospital & Healthcare Services
Invicta Meditek Limited (Invicta) incorporated in 1992 is a Public Limited company engaged in the manufacture of quality Orthopaedic Implants and Instruments.Invicta Meditek manufacture the quality Orthopaedic Implants and Instruments. Invicta serves the field of Orthopaedics by supplying...

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Value Creation
 Mar'09Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18
Return on Capital Employed -43.46%-16.3%-8.1%-5.16%-6.82%-6.81%-10.75%-12.14%-14.2%-20.17%
Growth Parameters
Growth Parameters Colour Code Guide
Net Sales (Rs. Cr.) 1.31.100.2000000
Y-o-Y Gr. Rt.--17.4%-100%NA-100%NANANANANA
Adjusted EPS (Rs.) -2.01-0.57-0.13-0.07-0.09-0.08-0.12-0.12-0.13-0.18
Y-o-Y Gr. Rt.-NANANANANANANANANA
Book Value per Share (Rs.) 1.380.811.421.351.261.171.050.930.810.03
Adjusted Net Profit -1.5-0.4-0.1-0.1-0.1-0.1-0.1-0.1-0.1-0.1
Net Op. Cash Flow (Rs. Cr.) -1.6-1.20-0.200000-0.1
Debt to Cash Flow from Ops -1.45-0.570000000-5.24
Standalone financials take only the parent company into account while consolidated financials take into account financials of the parent company as well as of all its subsidiaries. In most companies consolidated financials should be used for analysis.
Constronics Infra Ltd. should be analysed on a Standalone basis
CAGR
CAGR Colour Code Guide
  9 yrs 5 yrs 3 yrs 1 yr
Net Sales -100%NANANA
Adjusted EPS NANANANA
Book Value per Share -34.7-52.7-69.4-96.3
Share Price -11.2% 7.1% 19.6% 56%
Key Financial Parameter
Performance Ratio Colour Code Guide
 Mar'09Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18
Return on Equity (%) -154.93-51.75-11.44-5.2-6.86-6.88-10.77-12.17-14.42-42.43
Operating Profit Margin (%) -201.85-50.990-27.84000000
Net Profit Margin (%) -109.84-37.650-27.43000000
Debt to Equity 2.281.13000000027.42
Working Capital Days 46143102,035000000
Cash Conversion Cycle 203-1,1240630000000
Entity Percentage Holding
Promoters 16.58%
Non-Institutions 83.42%
Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)
Data is not available for this company.

The 5-year analysis of Constronics Infra Ltd's performance infers:

Constronics Infra Ltd earnings have grown by 0%, whereas share price has appreciated 7.1% CAGR over the past five years, indicating the company's share price is likely overvalued. However, for specific investment actions please connect with your investment advisor.

We analysed the performance of Constronics Infra Ltd share prices over the last 10 years. Here is what we found out:

Constronics Infra Ltd share price has appreciated 2.2% annually over the past ten years.

Invicta Meditek Limited (Invicta) incorporated in 1992 is a Public Limited company engaged in the manufacture of quality Orthopaedic Implants and Instruments.

Invicta Meditek manufacture the quality Orthopaedic Implants and Instruments. Invicta serves the field of Orthopaedics by supplying products for Total Joint Replacement systems, Trauma Implants and Associated Instruments. The product range also includes implants for Hemi-Arthroplasty, all types of Dynamic Compression and round hole

Invicta Meditek Limited (Invicta) incorporated in 1992 is a Public Limited company engaged in the manufacture of quality Orthopaedic Implants and Instruments.

Invicta Meditek manufacture the quality Orthopaedic Implants and Instruments. Invicta serves the field of Orthopaedics by supplying products for Total Joint Replacement systems, Trauma Implants and Associated Instruments. The product range also includes implants for Hemi-Arthroplasty, all types of Dynamic Compression and round hole plates, Screws with Cortical, Cancellous profiles, special thread sizes and in all diameters (with and without cannulation) and DHS/ DCS systems. The Joint Replacement Systems for Knee, Hip, Shoulder and Ankle are manufactured under license from Endotec Inc., USA.

Invicta has established a full-fledged machine shop with sophisticated, state of the art machinery required to meet the challenging, stringent quality requirements of the Orthopaedic implants and the high levels of accuracy required for the instruments used in joint replacement and other critical surgical operations.

Invicta lays special emphasis on achieving customer satisfaction by demonstrating the ability to consistently provide products that meet and exceed customer requirements. The Quality Control Department is equipped with the latest tools and instruments maintaining the strict quality standards demanded by the orthopaedic community.

Invicta’s product portfolio includes:-Total Joint Replacements for Knee, Hip, Ankle, Shoulder (under license from Endotec Inc., USA) -trauma implants (plates, screws, nails etc) -associated instrumentation

Product range of the company includes:

  • BP Hiflex Knee
  • Hip Implants
  • Trauma Implants
  • Conventional Implants
  • Instruments

Achievements/ recognition :

  • It is an ISO 13485-2003 & CE certified company.
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback